Trade Summary

4 days ago, Stanton Marshall S., serving as SVP, Clinical, MD Affair at Artivion, Inc. (AORT), sold 3,682 shares at $36.94 per share, for a total transaction value of $136,013.00. Following this transaction, Stanton Marshall S. now holds 41,921 shares of AORT.

This sale represents a 8.00% decrease in Stanton Marshall S.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Artivion, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.